International Clinical Trial: Efficacy of Eflornithine Hydrochloride Cream in the Treatment of Melasma: A Randomized, Double-blinded, Split-face Controlled Study

Geneva, May 28 -- International Clinical Trials Registry received information related to the study (NCT06957834) titled 'Efficacy of Eflornithine Hydrochloride Cream in the Treatment of Melasma: A Randomized, Double-blinded, Split-face Controlled Study' on May 2.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Crossover Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: National Skin Centre

Condition: Melasma

Intervention: Drug: Eflornithine hydrochloride cream

Recruitment Status: Not recruiting

Phase: Phase 2

Date of First Enrollment: June 6, 2023

Target Sample Size: 20

Countries of Recruitment: Si...